Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer
Clinical trial NCT02685657 · UNKNOWN
Trial details
- NCT number
- NCT02685657
- Sponsor
- Russian Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2018-01-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.